Cyclo(Arg-Gly-Asp-D-Phe-Val) TFA
Based on 1 Customer Validation
Cyclo(Arg-Gly-Asp-D-Phe-Val) (TFA) (Cyclo(RGDfV) (TFA))is an integrin αvβ3 inhibitor. Cyclo(Arg-Gly-Asp-D-Phe-Val) (TFA) has antitumor activity. Cyclo(Arg-Gly-Asp-D-Phe-Val) (TFA) can be used for the research of acute myeloid leukemia.
For research use only. We do not sell to patients.
- Purity : 99.40%
- CAS No.: 199807-33-5
- Formula: C28H39F3N8O9
- Molecular Weight:688.65
-
Storage:
Sealed storage, away from moisture.
Powder -80°C, 2 years , -20°C, 1 year* In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Biological Activity
-
Chemical Information
-
Solvent & Solubility
- Protocols
- Purity & Documentation
- References
-
Help & FAQs
-
HY-100506
GLPG0187Integrin Receptor Antagonist -
HY-P0290
GRGDSPIntegrin Inhibitor -
HY-16141
CilengitideIntegrin Inhibitor -
HY-P0031
Cyclo(RADfK)Control -
HY-17369
Tirofiban hydrochloride monohydrateGp IIb/IIIa Receptor Antagonist -
HY-13535
ATN-161α5β1/αvβ3 Integrin Binder -
HY-17369B
TirofibanGp IIb/IIIa Receptor Antagonist -
HY-12290
Arg-Gly-Asp-SerIntegrin Inhibitor -
HY-19344
LifitegrastLFA-1/ICAM-1 Antagonist -
HY-P0023
Cyclo(-RGDfK)αvβ3 Integrin Inhibitor -
HY-14571
E7820Angiogenesis Inhibitor -
HY-18644
CWHM-12αV Integrins Inhibitor
Biological Activity
Description
IC50 & Target
αvβ3[1]
In Vitro
Cyclo(Arg-Gly-Asp-D-Phe-Val) (TFA) (Cyclo(RGDfV) (TFA)) (35 nM, 4-24 h) disruptes the adhesion and migration between the tumor cells and the matrix, induces the leukemia cells to leave the protective microenvironment and increases their sensitivity to cell cycle-dependent agents[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
-
Cell Line:MV4-11 cells
-
Concentration:35 nM
-
Incubation Time:24 h
-
Result:Affected the leukemia cell cycle, decreased the G0/G1 phase of leukemia cells in the 3D and 2D culture systems and increased the S phase of leukemia cells in the 3D and 2D culture systems.
-
Cell Line:MV4-11 cells
-
Concentration:35 nM
-
Incubation Time:24 h
-
Result:Increased the apoptosis rates.
Chemical Information
-
CAS No. 199807-33-5
-
Appearance Solid
-
Molecular Weight 688.65
-
Formula C28H39F3N8O9
-
Color White to off-white
-
Synonyms
Cyclo(RGDfV) TFA; C(RGDfV) TFA
-
Sequence
Cyclo(Arg-Gly-Asp-{d-Phe}-Val)
-
Sequence Shortening
Cyclo(RGD-{d-Phe}-V)
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Sealed storage, away from moisture
Powder -80°C 2 years -20°C 1 year * In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)
Solvent & Solubility
In Vitro:
H2O : 2 mg/mL (2.90 mM; ultrasonic and warming and adjust pH to 2-3 with HCl)
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
* Note: If you choose water as the stock solution, please dilute it to the working solution, then filter and sterilize it with a 0.22 μm filter before use.
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
* Note: If you choose water as the stock solution, please dilute it to the working solution, then filter and sterilize it with a 0.22 μm filter before use.
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Protocols
-
Subcutaneous Cell-Line-Derived Xenograft
Subcutaneous cell-line-derived xenograft (CDX) models are established by implanting cultured human cancer cell lines into immunodeficient mice, where the injected cells form localized tumors that can be monitored in vivo as a measure of tumorigenic potential, growth kinetics, and treatment response. These models are widely used in oncology research because they allow reproducible tumor formation and enable comparative assessment of tumor growth between different cell lines or genetic manipulations in a controlled in vivo microenvironment. Subcutaneous implantation of cancer cells in immunodeficient mice is a standard approach for evaluating tumor growth behavior and therapeutic response across multiple cancer types, including prostate, esophageal, pancreatic, and colon cancer models.
Purity & Documentation
-
Data Sheet (278 KB)
-
SDS (252 KB)
- English - EN (252 KB)
- Français - FR (252 KB)
- Deutsch - DE (252 KB)
- Norwegian - NO (252 KB)
- Español - ES (252 KB)
- Swedish - SV (252 KB)
- Italian - IT (252 KB)
- Korean - KR (252 KB)
- Portuguese - PT (252 KB)
-
Handling Instructions (2659 KB)
References
Complete Stock Solution Preparation Table
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
| Optional Solvent | Concentration Solvent Mass | 1 mg | 5 mg | 10 mg | 25 mg |
|---|---|---|---|---|---|
| H2O | 1 mM | 1.4521 mL | 7.2606 mL | 14.5212 mL | 36.3029 mL |
* Note: If you choose water as the stock solution, please dilute it to the working solution, then filter and sterilize it with a 0.22 μm filter before use.
Cyclo(Arg-Gly-Asp-D-Phe-Val) TFA Related Classifications
HY-P1613A Related Classifications
Powered by Bioz